To view the full citation, click here.
Comparative Organ System Development: Continuing the Series
Birth Defects Research Part B: Developmental and Reproductive Toxicology, 2003
Open access, peer-reviewed publications ensure that knowledge is a public good. HESI believes that accessible research is critical for equitable engagement, diverse collaboration, and increased interdisciplinary conversation. We strive to achieve open access on all publications, and more than 200 publications from HESI programs have been published in the last decade.
Birth Defects Research Part B: Developmental and Reproductive Toxicology, 2003
To view the full citation, click here.
Frontiers in Toxicology, Nanotoxicology, 2022
Abstract: Genotoxicity testing is performed to determine potential hazard of a chemical or agent for direct or indirect DNA interaction. Testing may be a surrogate for assessment of heritable genetic risk or carcinogenic risk. Testing of nanomaterials (NM) for hazard identification is generally understood to require a ...
Birth Defects Research Part B: Developmental and Reproductive Toxicology, 2011
To view the full citation, click here.
Birth Defects Research Part B: Developmental and Reproductive Toxicology, 2011
To view the full citation, click here.
Perspectives in Experimental and Clinical Immunotoxicology, 2007
The primary T-cell dependent antibody response (TDAR) to antigens is widely used as a functional test in immunotoxicology.
Journal of Pharmacological and Toxicological Methods, 2024
The Health and Environmental Sciences Institute (HESI) Cardiac Safety Technical Committee (CSTC) has made significant strides in improving cardiovascular (CV) safety in drug development.
hesi@hesiglobal.org
Phone: +1-202-659-8404
Fax: +1-202-659-3859
740 15th Street NW, Suite 600
Washington, DC 20005
Sign up for our monthly e-newsletter.